1. Use of recombinant factor VIIa (NovoSeven[reg ]) in patients with Glanzmann thrombasthenia
- Author
-
R Musso, Christiane Guthner, Lilian Tengborn, Pia Petrini, Alison Street, Jonathan T. Wilde, Donald S. Houston, Brigitte Pautard, J rgen Ingerslev, Philippe Beurrier, Nathalie Trillot, Gabriele Strauss, A. Karafoulidou, Ian Hann, Lionel de Lumley, Herv Chambost, Stefan Kuhle, Claire Berger, Angela Huth-K hne, Angela Thomas, Christel Van Geet, Roseline d'Oiron, Christine Demers, Man-Chiu Poon, Claude N grier, Jose J. Lorenzo, Natascha Nohe, Pantelis E. Makris, Massimo Morfini, M. Vicariot, Omer Devecioglu, Marie-Fran oise Torchet, Majorlein Peters, Patricia Paugy, Edith Fressinaud, Alain Marqu s-Verdier, Willem Gerrits, Mario von Depka, Howard A. Britton, Mark Winter, and Stefan Lethagen
- Subjects
medicine.medical_specialty ,biology ,Recombinant factor VIIa ,business.industry ,Internal medicine ,Glanzmann thrombasthenia ,biology.protein ,medicine ,In patient ,Hematology ,business ,Gastroenterology - Published
- 2001
- Full Text
- View/download PDF